Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation

Abstract

Introduction

Upper gastrointestinal bleeding (UGIB) is an important complication among critically ill adults, especially those having cardiac surgery as management is complicated by the requirement for antiplatelet/anticoagulant therapy. As a result, stress ulcer prophylaxis (SUP) has become routine practice in many centers, utilizing either proton pump inhibitors (PPIs) or histamine-2 receptor blockers (H2RBs). Recent evidence from the PEPTIC trial indicated an increase in mortality risk among cardiac surgery patients receiving PPIs compared to H2RBs. Considering these findings, alongside practical difficulties surrounding the transition to H2RBs as a prophylactic agent in New Zealand, Wellington Hospital intensive care unit elected to discontinue routine PPI use for SUP in cardiac surgery patients. A retrospective study was conducted to assess patient outcomes following the discontinuation of routine SUP.

Method

A retrospective cohort study was conducted of all adult patients who underwent cardiac surgery at Wellington Hospital between February/2018 and January/2022, and divided patients into cohorts before and after the discontinuation of routine use of SUP on the 31st of January 2020. The primary outcomes were the rate of UGIB, oesophagogastroduodenoscopy (OGD) and 180-day postoperative mortality. Secondary outcomes included rates of postoperative Clostridium difficile enteritis, pneumonia, deep sternal wound infection, and length of stay of the index admission.

Results

The rate of UGIB statistically significantly increased since the cessation of routine SUP in January 2020 (2.4% vs 5.4%, P-value = .004). This finding was mirrored with the increased rates of OGD (1.9% vs 4.0%, P-value = .005). There were no significant changes in 180-day mortality, hospital length of stay, or any of the postoperative infective complications analyzed, pneumonia, deep sternal wound infection, or C difficile enteritis.

Conclusion

This study suggests an association between routine use of SUP and reduced rates of clinically significant UGIB and OGD requirements in cardiac surgery patients without increasing risk of infective complications or postoperative mortality.

Keywords

Intensive care unit outcomes adverse events bleeding cardiac surgery complications coronary artery bypass grafting critical care intensive care unit infections

Get full access to this article

View all access options for this article.

References

Krag

Perner

Wetterslev

, et al. SUP-ICU co-authors. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med. 2015;41(5):833-845. https://doi.org/10.1007/s00134-015-3725-1

Barbateskovic

Marker

Granholm

, et al. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2019;45(2):143-158. https://doi.org/10.1007/s00134-019-05526-z.

PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group, Alberta Health Services Critical Care Strategic Clinical Network, and the Irish Critical Care Trials Group, Young

Bagshaw

, et al. Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: The PEPTIC randomized clinical trial. JAMA. 2020;323(7):616-626. https://doi.org/10.1001/jama.2019.22190

Mahase

. FDA recalls ranitidine medicines over potential cancer-causing impurity. BMJ (Clinical Research ed.). 2019;367:l5832. https://doi.org/10.1136/bmj.l5832.

Vaduganathan

Bhatt

Cryer

, et al. Proton-pump inhibitors reduce gastrointestinal events regardless of aspirin dose in patients requiring dual antiplatelet therapy. J Am Coll Cardiol. 2016;67(14):1661-1671. https://doi.org/10.1016/j.jacc.2015.12.068

Biswas

Benedict

Lynch

, et al. Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis. BMC Med. 2012;10:57. https://doi.org/10.1186/1741-7015-10-57.

Cook

Guyatt

. Prophylaxis against upper gastrointestinal bleeding in hospitalized patients. N Engl J Med. 2018;378(26):2506-2516. https://doi.org/10.1056/NEJMra1605507.

Kedika

Souza

Spechler

. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci. 2009;54(11):2312-2317. https://doi.org/10.1007/s10620-009-0951-9.

Aybay

Imir

Okur

. The effect of omeprazole on human natural killer cell activity. General Pharmacology: The Vascular System. 1995;26(6):1413-1418. https://doi.org/10.1016/0306-3623(94)00301-3.

10.

Makris

Crott

Fallone

Bardou

Barkun

. Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia. Gastrointest Endosc. 2003;58(1):14-22. https://doi.org/10.1067/mge.2003.295.

11.

Mekhail

Galvin

. The effects of the COVID-19 pandemic on cardiac surgery volumes and outcomes in New Zealand. Heart Surg Forum. 2022;25(3):E358-E363. https://doi.org/10.1532/hsf.4719.